Fatal esorubicin-induced cardiomyopathy:
✍
Louis F. Diehl; Alan Banks; Wendy Carter; Michael A. Klein; Hyman B. Muss; Raymo
📂
Article
📅
1988
🏛
Springer
🌐
English
⚖ 378 KB
A case of fatal dilated cardiomyopathy induced by esorubicin (ESO) at a total dose of 740 mg/m2, given in 27 doses over 650 days, is reported. The sudden onset, rapid clinical deterioration, and fatal outcome are detailed. The outcome was not predicted by serial rest ejection fractions or clinical s